cancer chemotherapy · reviewed 2026-08-01
Vincristine and Madagascar periwinkle: the exact plant alkaloid is not the whole plant
Vincristine is an unchanged alkaloid obtained from Madagascar periwinkle and formulated as an intravenous cancer medicine. Whole plant material is not the sterile measured injection and cannot inherit the purified drug's leukemia evidence.
Defined medicine
vincristine
vincristine sulfate · leurocristine · VCR
Where it came from
Vincristine is the same complex alkaloid obtained from the flowering Madagascar periwinkle, historically named Vinca rosea and now Catharanthus roseus. The pharmaceutical sulfate salt preserves that natural active molecule. dailymed-vincristine
What it is trying to achieve
Vincristine injection is labelled for acute leukemia and as part of specified combination regimens for several lymphomas and childhood solid tumours. Its role commonly depends on multi-drug oncology care. dailymed-vincristine
How it acts
Vincristine disrupts microtubule formation in the mitotic spindle and arrests dividing cells at metaphase. Microtubules also support neurons, helping explain its distinctive neurotoxicity. dailymed-vincristine
Why people developed this form
NCI's timeline records vincristine among the anticancer medicines approved during the early national screening era. The label, rather than that timeline, establishes its exact combinations, route, handling, and toxicity controls. nci-vinca dailymed-vincristine
Present form and manufacture
The cited product is a sterile, preservative-free vincristine sulfate solution for intravenous use only. Administration by the intrathecal route is usually fatal, making route control part of the medicine itself. dailymed-vincristine
Bioavailability
Intravenous delivery gives direct systemic exposure followed by rapid tissue distribution, prolonged terminal elimination, hepatic CYP3A metabolism, and mainly biliary or fecal excretion. Liver function and interactions matter. dailymed-vincristine
Its own risks
Dose-related peripheral and autonomic neuropathy, constipation or ileus, tissue injury after leakage, fetal harm, interactions, and fatal wrong-route errors are central risks. Oncology handling controls are essential. dailymed-vincristine
What nature offers
No link below is assumed to be equivalent. Each names the organism or tradition, exact preparation, measured exposure, human evidence, and replacement boundary separately.
Nature link · Same molecule occurs in nature
Madagascar periwinkle
Catharanthus roseus
rosy periwinkle · Vinca rosea
- Exact material
- Whole Catharanthus roseus plant material is distinguished from the vincristine alkaloid obtained from the plant and from sterile vincristine sulfate injection. dailymed-vincristine
- Relationship
- Same molecule occurs in nature. Chemical identity may match, but purity, amount, formulation, route, companion compounds, and evidence can still differ.
Lineage
The label identifies periwinkle as the source of vincristine. This is exact natural-product extraction, not a loose resemblance or a later molecule inspired by the plant. dailymed-vincristine
Traditional context
Neither the product label nor NCI's approval timeline supplies evidence for a named traditional anticancer preparation. This card therefore does not invent a cultural cancer indication for the whole plant. nci-vinca dailymed-vincristine
Human evidence
Source, not an intervention Evidence product match: not applicable
Whole periwinkle is the molecular source, not the product tested in leukemia and combination chemotherapy. The label's outcome evidence cannot be assigned to leaves, flowers, roots, powders, or extracts. dailymed-vincristine
Bioavailability and preparation
A plant part has no predictable vincristine exposure and no bridge to sterile intravenous delivery. Alkaloid identity, concentration, extraction, degradation, and oral absorption all differ from the labelled product. dailymed-vincristine ema-herbal-biopharm
Safety
The label establishes severe neurotoxicity and fatal wrong-route risk for purified vincristine, while it supplies no safety standard for whole plant material. Botanical origin therefore cannot establish a gentler product. dailymed-vincristine
Can it replace the medicine?
Periwinkle makes vincristine, but whole plant material is not a measurable or clinically supported replacement for oncology-grade vincristine sulfate. dailymed-vincristine
The honest comparison
Vincristine is fully natural as a molecule and fully pharmaceutical as an intervention. Purity, sterile formulation, intravenous route, combination context, and specialist safeguards separate it from the plant. dailymed-vincristine
The label directly credits Madagascar periwinkle as vincristine's source, while NCI's timeline records the medicine's 1963 approval. Neither fact makes periwinkle material home chemotherapy or a safer version of vincristine. dailymed-vincristine nci-vinca
Sources for this card
- Vincristine sulfate injection label DailyMed · regulatory label · read 2026-08-01
- Developmental Therapeutics Program history US National Cancer Institute · official history · read 2026-08-01
- Points to consider on the biopharmaceutical characterisation of herbal medicinal products European Medicines Agency · official guidance · read 2026-08-01
Same card as data: /api/remedies/vincristine-madagascar-periwinkle.json. Found a source or claim problem? Open a correction.